A new study reveals that one-fifth of young adult cancer survivors exhibit symptoms of posttraumatic stress disorder, a condition characterized by overwhelming anxiety and fear. The study found a four-fold increase in PTSD diagnosis among young adults compared to those aged 9-17.
A large study of 381 postmenopausal women found no association between high fat intake and increased estrogen levels, contrary to long-held assumptions. The researchers concluded that reducing fat intake to lower hormone levels is unlikely to be a useful strategy in preventing breast cancer.
Two studies found that common screening techniques for tamoxifen-induced endometrial cancer are ineffective. Tissue biopsies and transvaginal ultrasound screenings detected few abnormalities and led to unnecessary procedures. Patients should be reassured and monitored for abnormal vaginal bleeding instead.
A survey of 3,299 oncologists found a significant decline in support for euthanasia and physician-assisted suicide, with those trained in end-of-life care less likely to support these options. The study emphasizes the need for education on providing high-quality palliative care to dying patients.
A recent study conducted at Indiana University Medical Center found that high-dose chemotherapy followed by stem-cell transplantation can achieve a durable remission in approximately 50% of patients with recurrent testicular cancer. The overall cure rate for these patients is now estimated to be around 85 percent.
Researchers found radiation therapy to be both safe and effective in preventing cancer recurrence in women with BRCA1 or BRCA2 mutations. However, women with these genetic mutations were more likely to develop cancer in their unaffected breast.
A study found that six months of care for patients in phase II clinical trials costs $57,542, similar to $63,721 for those receiving standard treatment. This research suggests insurers can improve healthcare without financial risk.
A new diagnostic tool is highly accurate in detecting cancer spread in women with vulva cancer, potentially sparing them from debilitating lymph node removal. Researchers found that 27 out of 59 patients had cancer spread, and the procedure could spare up to 80% of women from this procedure.